BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8009838)

  • 21. Mason-Pfizer monkey virus (MPMV) constitutive transport element (CTE) functions in a position-dependent manner.
    Rizvi TA; Schmidt RD; Lew KA
    Virology; 1997 Sep; 236(1):118-29. PubMed ID: 9299624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cloning and functional analysis of multiply spliced mRNA species of human immunodeficiency virus type 1.
    Schwartz S; Felber BK; Benko DM; Fenyö EM; Pavlakis GN
    J Virol; 1990 Jun; 64(6):2519-29. PubMed ID: 2335812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potent knock down of HIV-1 replication by targeting HIV-1 Tat/Rev RNA sequences synergistically with catalytic RNA and DNA.
    Sood V; Unwalla H; Gupta N; Chakraborti S; Banerjea AC
    AIDS; 2007 Jan; 21(1):31-40. PubMed ID: 17148965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Presence of negative and positive cis-acting RNA splicing elements within and flanking the first tat coding exon of human immunodeficiency virus type 1.
    Amendt BA; Hesslein D; Chang LJ; Stoltzfus CM
    Mol Cell Biol; 1994 Jun; 14(6):3960-70. PubMed ID: 8196635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tat is required for efficient HIV-1 reverse transcription.
    Harrich D; Ulich C; García-Martínez LF; Gaynor RB
    EMBO J; 1997 Mar; 16(6):1224-35. PubMed ID: 9135139
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chapter 1. Regulation of HIV-1 alternative RNA splicing and its role in virus replication.
    Stoltzfus CM
    Adv Virus Res; 2009; 74():1-40. PubMed ID: 19698894
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Two strong 5' splice sites and competing, suboptimal 3' splice sites involved in alternative splicing of human immunodeficiency virus type 1 RNA.
    O'Reilly MM; McNally MT; Beemon KL
    Virology; 1995 Nov; 213(2):373-85. PubMed ID: 7491762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The tat/rev intron of human immunodeficiency virus type 1 is inefficiently spliced because of suboptimal signals in the 3' splice site.
    Staffa A; Cochrane A
    J Virol; 1994 May; 68(5):3071-9. PubMed ID: 7512159
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of rev gene function on human immunodeficiency virus type 1 replication in lymphoid cells by using a quantitative polymerase chain reaction method.
    Arrigo SJ; Weitsman S; Rosenblatt JD; Chen IS
    J Virol; 1989 Nov; 63(11):4875-81. PubMed ID: 2677405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repair of a Rev-minus human immunodeficiency virus type 1 mutant by activation of a cryptic splice site.
    Verhoef K; Bilodeau PS; van Wamel JL; Kjems J; Stoltzfus CM; Berkhout B
    J Virol; 2001 Apr; 75(7):3495-500. PubMed ID: 11238879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overlapping cis sites used for splicing of HIV-1 env/nef and rev mRNAs.
    Swanson AK; Stoltzfus CM
    J Biol Chem; 1998 Dec; 273(51):34551-7. PubMed ID: 9852125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The exon splicing silencer in human immunodeficiency virus type 1 Tat exon 3 is bipartite and acts early in spliceosome assembly.
    Si ZH; Rauch D; Stoltzfus CM
    Mol Cell Biol; 1998 Sep; 18(9):5404-13. PubMed ID: 9710624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The rev gene of visna virus is required for productive infection.
    Toohey KL; Haase AT
    Virology; 1994 Apr; 200(1):276-80. PubMed ID: 7510438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Presence of exon splicing silencers within human immunodeficiency virus type 1 tat exon 2 and tat-rev exon 3: evidence for inhibition mediated by cellular factors.
    Amendt BA; Si ZH; Stoltzfus CM
    Mol Cell Biol; 1995 Aug; 15(8):4606-15. PubMed ID: 7623852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A naturally arising mutation of a potential silencer of exon splicing in human immunodeficiency virus type 1 induces dominant aberrant splicing and arrests virus production.
    Wentz MP; Moore BE; Cloyd MW; Berget SM; Donehower LA
    J Virol; 1997 Nov; 71(11):8542-51. PubMed ID: 9343212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simian immunodeficiency virus displays complex patterns of RNA splicing.
    Viglianti GA; Sharma PL; Mullins JI
    J Virol; 1990 Sep; 64(9):4207-16. PubMed ID: 2384918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinetics of viral RNA synthesis following cell-to-cell transmission of human immunodeficiency virus type 1.
    Davis AJ; Li P; Burrell CJ
    J Gen Virol; 1997 Aug; 78 ( Pt 8)():1897-906. PubMed ID: 9266985
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of the tnv protein and tnv RNA splicing signals in replication of HIV-1 IIIB isolates.
    Göttlinger HG; Dorfman T; Cohen EA; Haseltine WA
    Virology; 1992 Aug; 189(2):618-28. PubMed ID: 1641982
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of human immunodeficiency virus 1 (HIV-1) envelope gene products transcribed from a heterologous promoter. Kinetics of HIV-1 envelope processing in transfected cells.
    Bird C; Burke J; Gleeson PA; McCluskey J
    J Biol Chem; 1990 Nov; 265(31):19151-7. PubMed ID: 2229068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of a cryptic splice donor in human immunodeficiency virus type-1.
    Borg KT; Favaro JP; Arrigo SJ; Schmidt M
    J Biomed Sci; 1999 Jan; 6(1):45-52. PubMed ID: 9933742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.